Abstract
The Pharmacogenomics Access & Reimbursement Symposium, a landmark event presented by the Golden Helix Foundation and the Pharmacogenomics Access & Reimbursement Coalition, was a 1-day interactive meeting comprised of plenary keynotes from thought leaders across healthcare that focused on value-based strategies to improve patient access to personalized medicine. Stakeholders including patients, healthcare providers, industry, government agencies, payer organizations, health systems and health policy organizations convened to define opportunities to improve patient access to personalized medicine through best practices, successful reimbursement models, high quality economic evaluations and strategic alignment. Session topics included health technology assessment, health economics, health policy and value-based payment models and innovation.
| Original language | English |
|---|---|
| Pages (from-to) | 515-517 |
| Number of pages | 3 |
| Journal | Pharmacogenomics |
| Volume | 22 |
| Issue number | 9 |
| DOIs | |
| State | Published - Jun 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 9 Industry, Innovation, and Infrastructure
Keywords
- COVID-19
- health economics
- health policy
- health technology assessment
- innovation
- patient access
- payment models
- pharmacogenetics testing
- pharmacogenomics
- precision medicine
- reimbursement
Fingerprint
Dive into the research topics of 'Inaugural Pharmacogenomics Access and Reimbursement Symposium'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver